GLENN JOHN
CFO
GLENN JOHN has filed 4 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jun 23, 2026.
On the most recent filing, GLENN JOHN is listed as CHIEF FINANCIAL OFFICER at IRADIMED CORP. Inside the rolling window, GLENN JOHN reported no open-market purchases and 2 open-market sales totaling $2.4M in IRMD. The largest disclosed transaction in the window is a sale of 15,000 IRMD shares on Dec 11, 2025, worth $1.5M.
Companies traded
Other insiders at IRMD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GLENN JOHN made?
GLENN JOHN has filed 4 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does GLENN JOHN trade?
GLENN JOHN has filed SEC Form 4 disclosures for 1 company, including IRMD.
When was GLENN JOHN's most recent SEC Form 4 filing?
GLENN JOHN's most recent SEC Form 4 filing on Tracefour is dated Jun 23, 2026.
What is GLENN JOHN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, GLENN JOHN is listed as CFO.
What is GLENN JOHN's total buy and sell value in the current window?
Inside the rolling retention window, GLENN JOHN bought $0 and sold $2.4M based on SEC Form 4 filings.
What was GLENN JOHN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 IRMD shares on 2025-12-11, worth $1.5M, per SEC Form 4 filings.